BMO Capital downgraded 4D Molecular (FDMT) to Market Perform from Outperform with a price target of $15, down from $40. 4D-150 durability in ...

An update from a Montana friend in her annual Christmas letter about a physical therapist named Bone inspires me to offer the ...

This year’s CES was all about AI—or at least, that was the headline. While AI is poised to change everything, its presence at the show was more theoretical than tangible.

Dates are a popular and versatile snack enjoyed by people of all ages. Their health benefits, packed with essential nutrients, make them a must-have in your daily diet. While dates are calorie-dense ...

Dates are a nutritious fruit with high fiber and antioxidant content. Consuming two dates daily can enhance bowel movements, ...

4D Molecular Therapeutics is axing two clinical programs and cutting off funds for three other assets, with resources to be ...

Baker Tilly Wealth Management LLC lowered its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 30.2% ...

BMO Capital analyst Kostas Biliouris downgraded the rating on 4D Molecular Therapeutics (FDMT – Research Report) to a Hold today, setting a ...

Steven Bird was a man who would go out of his way to help seniors or others who, like him, were disabled. He advocated for ...

Maintaining good eyesight is more critical than ever in today's fast-paced world. With rising screen time and environmental ...

In addition to these accolades, Brinton Vision has previously been recognized by St. Louis Magazine’s A-List Readers’ Choice Awards, winning the No. 1 LASIK Center title three years in a row. This ...

Glaucoma, the second leading cause of blindness globally, affects millions and is projected to reach 111.8 million cases by ...